| Trial ID: | L4054 |
| Source ID: | NCT01273558
|
| Associated Drug: |
Canagliflozin
|
| Title: |
A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Canagliflozin
|
| Outcome Measures: |
Primary: RTG values using the MMTT and the stepwise hyperglycemic clamp methods, On Days 1 and 2 (Part 1)|RTG values using the MMTT and the stepwise hyperglycemic clamp methods, On Days 7 and 8 (Part 2) | Secondary: Plasma glucose (PG) concentration during the MMT and the hyperglycemic clamp procedure, On Days 1 and 2 (Part 1)|Plasma glucose (PG) concentration during the MMT and the hyperglycemic clamp procedure, On Days 7 and 8 (Part 2)|Rate of Urinary glucose excretion (UGE) during the MMTT and the hyperglycemic clamp procedure, On Days 1 and 2 (Part 1)|Rate of Urinary glucose excretion (UGE) during the MMTT and the hyperglycemic clamp procedure, On Days 7 and 8 (Part 2)
|
| Sponsor/Collaborators: |
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-01
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2013-04-22
|
| Locations: |
Neuss, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01273558
|
